When is asparagus not asparagus? Why, when it’s ginger, of course!

Allow us to explain that headline. Food Science & Nutrition has retracted a 2018 article by a group of researchers in China and Pakistan for plagiarism. The article was titled “Experimentally investigated the asparagus (Asparagus officinalis L.) drying with flat-plate collector under the natural convection indirect solar dryer.”   Per the retraction notice: The retraction … Continue reading When is asparagus not asparagus? Why, when it’s ginger, of course!

Graduate student in China stripped of PhD after investigation that led to a dozen retractions

On Friday we reported on the case of a group of researchers in China who have retracted at least 11 papers for various kinds of misconduct. Here’s a bit more on that story, courtesy of our commenters. First, it turns out that the retraction total is at least 12. But more significant is that the … Continue reading Graduate student in China stripped of PhD after investigation that led to a dozen retractions

Group in China earns nearly a dozen retractions for image duplication, forged authorship, and more

A group of materials scientists in China has earned 11 retractions and three corrections — so far — for image manipulation, duplication, deceptive authorship and other misconduct. The papers, from a group at the prestigious Tsinghua University, appeared in a variety of materials journals and date back to 2014. The most recent publications arrived in … Continue reading Group in China earns nearly a dozen retractions for image duplication, forged authorship, and more

“Sufficiently serious” issues in study prompt company to yank drug approval application in China

The maker of a leading over-the-counter antacid has withdrawn its application for approval of the drug in China because a clinical trial of the product in that country was marred by “major protocol deviations.” Researchers for the company, Reckitt Benckiser, maker of Gaviscon, had published a report on the study in 2015 in the journal … Continue reading “Sufficiently serious” issues in study prompt company to yank drug approval application in China

“Irreconcilable” differences about author order, other issues topple two articles in Spandidos journal

Researchers in China have retracted a pair of papers in the same journal after running into “irreconcilable” differences with the articles. Both articles appeared in Molecular Medicine Reports, from Spandidos. One article, “Combined treatment with extracorporeal shock‑wave therapy and bone marrow mesenchymal stem cell transplantation improves bone repair in a rabbit model of bone nonunion,” … Continue reading “Irreconcilable” differences about author order, other issues topple two articles in Spandidos journal

Persistence pays off for plagiarized author: emails spur retraction, sanctions against researcher

Here’s an object lesson for scientists who find out they’ve been ripped off by other researchers: Taking matters into your own hands can produce results.   An aggrieved author’s doggedness led to the retraction of a 2013 paper that plagiarized his work, along with the revocation of a doctoral degree by one of the scientists … Continue reading Persistence pays off for plagiarized author: emails spur retraction, sanctions against researcher

Hey journals, it is possible to quickly correct the record

Even when a paper is obviously flawed, it can take years for journals to take action. Some never do. But it doesn’t have to be that way. On April 27, a reader emailed the editors of two journals, noting that each had recently published a paper by the same group of authors that appeared strikingly … Continue reading Hey journals, it is possible to quickly correct the record

Now-retracted chem paper’s problems “should have been noticed by the referees,” group says

Last year, chemist Marcus Tius at the University of Hawaii saw a paper describing the synthesis of some organic compounds, and was “struck by the implausibility” of the reported structures. So he joined up with some colleagues to try to replicate the data. While Tius and his team were trying to repeat the experiment, however, … Continue reading Now-retracted chem paper’s problems “should have been noticed by the referees,” group says

Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Title: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported … Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Caught Our Notice: 54 problems in three scientific images equals one expression of concern

Title: Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain What Caught Our Attention: Usually, an Expression of Concern (EOC) offers general language about “concerns regarding the validity of the data” or “concerns regarding the integrity of the study.” Here the language is anything but, saying that … Continue reading Caught Our Notice: 54 problems in three scientific images equals one expression of concern